All Pharma News
Kineta Reports Initial Clinical Response Data at AACR 2024

Kineta Reports Initial Clinical Response Data at AACR 2024
GLOBENEWSWIRE
08 Apr 2024
Share Share
Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update

Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update
GLOBENEWSWIRE
21 Mar 2024
Share Share
KVA12123 Clears Cohorts in Monotherapy in the Phase 1/2 VISTA-101 Trial

KVA12123 Clears Cohorts in Monotherapy in the Phase 1/2 VISTA-101 Trial
GLOBENEWSWIRE
12 Mar 2024
Share Share
Kineta Announces Restructuring and Exploration of Strategic Alternatives

Kineta Announces Restructuring and Exploration of Strategic Alternatives
GLOBENEWSWIRE
29 Feb 2024
Share Share
Kineta faces shutdown as private placement fails to show up

Kineta faces shutdown as private placement fails to show up
Annalee Armstrong FIERCE BIOTECH
29 Feb 2024
Share Share
Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123

Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123
GLOBENEWSWIRE
22 Feb 2024
Share Share
Kineta to Present at Upcoming Investor Conferences

Kineta to Present at Upcoming Investor Conferences
GLOBENEWSWIRE
14 Feb 2024
Share Share
Kineta to Participate in H.C. Wainwright Virtual @Home Fireside Chat Series

Kineta to Participate in H.C. Wainwright Virtual @Home Fireside Chat Series
GLOBENEWSWIRE
07 Feb 2024
Share Share
Kineta Provides Update on its Phase 1/2 VISTA-101 Clinical Trial of KVA12123

Kineta Provides Update on its Phase 1/2 VISTA-101 Clinical Trial of KVA12123
GLOBENEWSWIRE
17 Jan 2024
Share Share
Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event
GLOBENEWSWIRE
04 Jan 2024
Share Share